亲身使用，非常有帮助
去年疫情封控开始频繁惊恐发作，一直药物控制，但还是很焦虑。网上了解到渐静，用了一段时间，效果还是非常好的，对于惊恐发作完全不担心害怕了。非常推荐。
Description
「渐静」采用认知行为疗法，基于你的惊恐情况，为你定制为期6周的个性化干预方案。通过深入浅出的治疗知识学习，了解惊恐发作的底层原理。通过针对性的行为训练，熟悉并克服惊恐发作的不适感，让你找回对身体的掌控感。学会科学地面对你所回避的情境或场所，从此不畏恐惧，轻松前行。
本软件不提供诊断或辅助诊断。用户的治疗建议以医嘱为主，本软件提供的治疗建议仅供参考。
本软件不提供诊断或辅助诊断。用户的治疗建议以医嘱为主，本软件提供的治疗建议仅供参考。
Screenshots
渐静 FAQ
-
Is 渐静 free?
Yes, 渐静 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 渐静 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 渐静 cost?
渐静 is free.
-
What is 渐静 revenue?
To get estimated revenue of 渐静 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Egypt yet.
Ratings History
渐静 Reviews
Store Rankings
Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet
渐静 Competitors
| Name | Downloads (30d) | Monthly Revenue | Reviews | Ratings | Recent release | |
|---|---|---|---|---|---|---|
术愈医生-康复管理
术愈与你无间陪伴
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
术愈-肺部肿瘤康复管理
赋能肺癌患者术后加速康复
|
Unlock
|
Unlock
|
0
|
|
2 years ago | |
脑医咨询
医患沟通桥梁
|
Unlock
|
Unlock
|
0
|
|
7 months ago | |
美高CBTI
睡眠数字疗法，高效助眠
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
绵羊睡眠（健康版）
|
Unlock
|
Unlock
|
0
|
|
3 years ago | |
知优眠研究版
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
聚医生
聚医生，让医生更便捷的为患者提供诊疗服务
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
聆忧
|
Unlock
|
Unlock
|
0
|
|
10 months ago | |
Pulse Plus -运动、心理康复治疗工具
专业的智能化数字疗法和健康服务平台
|
Unlock
|
Unlock
|
0
|
|
1 year ago | |
嗅康
|
Unlock
|
Unlock
|
0
|
|
1 year ago |
渐静 Installs
Last 30 days
渐静 Revenue
Last 30 days渐静 Revenue and Downloads
Gain valuable insights into 渐静 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Medical
- Publisher
- 上海特霍芬智能科技有限公司
- Languages
- English, Chinese
- Recent release
- 1.0.5 (1 year ago )
- Released on
- Nov 16, 2022 (2 years ago )
- Also available in
- China , Australia , Mexico , Philippines , Peru , New Zealand , Norway , Netherlands , Nigeria , Malaysia , Poland , Lebanon , Kazakhstan , Kuwait , South Korea , Japan , Italy , Pakistan , Israel , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Algeria , Argentina , Austria , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , Dominican Republic , India , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Croatia , Hungary , Indonesia , Ireland , United Arab Emirates
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.